Your browser doesn't support javascript.
loading
The value of walking: a systematic review on mobility and healthcare costs.
Wohlrab, Martin; Klenk, Jochen; Delgado-Ortiz, Laura; Chambers, Michael; Rochester, Lynn; Zuchowski, Matthias; Schwab, Matthias; Becker, Clemens; Jaeger, Simon U.
Afiliação
  • Wohlrab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstrasse 112, 70376, Stuttgart, Germany.
  • Klenk J; University of Tuebingen, Tuebingen, Germany.
  • Delgado-Ortiz L; Robert-Bosch Gesellschaft Für Medizinische Forschung, Stuttgart, Germany.
  • Chambers M; Institute of Epidemiology and Medical Biometry, Ulm University, 89081, Ulm, Germany.
  • Rochester L; IB University of Health and Social Sciences, Study Center Stuttgart, 70178, Stuttgart, Germany.
  • Zuchowski M; ISGlobal, Barcelona, Spain.
  • Schwab M; Universitat Pompeu Fabra, Barcelona, Spain.
  • Becker C; CIBER Epidemiología Y Salud Pública, Barcelona, Spain.
  • Jaeger SU; MC Healthcare Evaluation, London, UK.
Eur Rev Aging Phys Act ; 19(1): 31, 2022 Dec 29.
Article em En | MEDLINE | ID: mdl-36581809
ABSTRACT

BACKGROUND:

The ability to walk is an important indicator of general health and mobility deficits have wide-ranging economic implications. We undertook a systematic review to elucidate the impact of walking parameters on health care costs

METHODS:

Publications reporting on associations between health care costs and walking parameters were identified by a systematic literature search in MEDLINE, Embase, and manual reference screening, following the PRISMA reporting guidelines. First, titles and abstracts were screened by two independent reviewers followed by a review of the full articles if they met the inclusion criteria. Costs were converted to US-Dollars with inflation adjustment for 2021. A narrative synthesis was performed. 

RESULTS:

Ten studies conducted between 2001 and 2021 fulfilled the inclusion criteria. Assessment of walking ability was carried out via patient reported outcomes, performance tests, or using wearable digital devices. Walking more than one hour per day, a faster walking speed and the ability to walk without impairments are associated with significant lower health care costs. A higher number of steps per day is associated with significant lower costs in two simulation studies, while in the study using a digital device, taking more than 10,000 steps per day is not significantly associated with lower direct costs. The heterogeneity of mobility assessments and of economic analyses both precluded a quantitative synthesis.

CONCLUSION:

Cross-sectional and observational studies from this systematic review suggest a significant association of better walking performance with lower health care costs. Future health economic research and health technology assessments should use quantifiable mobility outcomes when evaluating new drugs or non-pharmacological interventions.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Health_technology_assessment / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Health_technology_assessment / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article